IBOGAINE, an alkaloid found in the root bark of the African shrub Tabe
rnanthe iboga, has been claimed to interrupt opioid dependence in huma
ns; in animals, it has been shown to inhibit morphine self-administrat
ion and to attenuate signs of morphine withdrawal. However, ibogaine h
as some neurotoxicity, and because of this, efficacious and safer cong
eners of ibogaine have been sought. 18-Methoxycoronaridine (18-MG), a
novel iboga alkaloid congener, has been shown, in animals, to mimic th
e effects of ibogaine on morphine self-administration without producin
g any ibogaine-like neurotoxiticity. In the present study, 18-MG was s
hown to attenuate five of seven signs of morphine withdrawal in rats.
The data suggest that 18-MG will ameliorate symptoms of opioid depende
nce in humans. (C) 1998 Rapid Science Ltd.